Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DA-EPOCH for NHL-associated HLH
NCT01818908Phase 2Unknown
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Jun 2012
- Primary completion
- Oct 2018
- Modality
- Monoclonal Antibodies, DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin in non-Hodgkin lymphoma (NHL), hemophagocytic lymphohistiocytosis (HLH), sponsored by Jiangsu Provincial People's Hospital. Status: unknown.
02
Drugs
etoposideprednisonevincristinecyclophosphamidedoxorubicin
03
Conditions
non-Hodgkin lymphoma (NHL)hemophagocytic lymphohistiocytosis (HLH)
Beyond the preview
Go deeper on NCT01818908.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01818908.